Federated Hermes
DERM icon

Federated Hermes’s Journey Medical DERM Stock Holding History

Federated Hermes’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$675 Hold
144
– – ﹤0.01% 2022
2025
Q4 		$1.11K Buy
+144
New +$1.13K ﹤0.01% 2012
2024
Q4 		– Sell
-853
Closed -$4.82K – 2103
2024
Q3 		$4.82K Sell
853
-476
-36% -$2.45K ﹤0.01% 1861
2024
Q2 		$7.5K Hold
1,329
– – ﹤0.01% 1804
2024
Q1 		$4.89K Buy
1,329
+496
+60% +$2.16K ﹤0.01% 1841
2023
Q4 		$4.8K Buy
+833
New +$3.71K ﹤0.01% 1860

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Federated Hermes's DERM Position: Q1 2026 in Review

Federated Hermes held its Journey Medical (DERM) position steady in Q1 2026 at 144 shares worth $675. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Federated Hermes first reported a position in DERM in Q4 2023 and has held it in 6 quarters since. The position peaked at $7.5K in Q2 2024. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Federated Hermes held 144 shares of Journey Medical worth $675 as of Q1 2026.
  • Federated Hermes left its Journey Medical share count unchanged in Q1 2026.
  • Journey Medical made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #2022 holding.
  • Federated Hermes first reported a position in Journey Medical in Q4 2023 and has held it in 6 quarters since.
  • Federated Hermes's Journey Medical position peaked at $7.5K in Q2 2024.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.